What question did this study set out to answer?

The study aims to assess the immune modulation and efficacy of PSMA-targeted alpha therapy in a newly established immunocompetent prostate cancer model.

April 5, 2026Cancer Research

Evaluation of 212Pb-PSMA Radioligand Therapy in Prostate Cancer Models

View Full Paper

Ask AI

Bookmark

The study aims to assess the immune modulation and efficacy of PSMA-targeted alpha therapy in a newly established immunocompetent prostate cancer model.
Established a syngeneic prostate cancer model expressing murine PSMA (mPSMA) using a bone-metastatic cell line.
Assessed the binding affinity and specificity of the radioligand 212Pb-PS0001 via inhibition and cytotoxicity assays.
Conducted biodistribution and therapeutic efficacy assessments in C57BL/6 mice with mPSMA-RM1-BM tumors.
Performed multiomics analyses on samples to characterize immune responses post-treatment.
RM1-BM-mFOLH1 cells showed mPSMA expression akin to human PSMA-positive cells.
212Pb-PS0001 demonstrated high tumor uptake with minimal off-target effects in RM1-BM-mFOLH1 models.
Single treatment with 212Pb-PS0001 significantly inhibited tumor growth in immunocompetent mice, unlike untreated controls.
Some treated subjects maintained tumor control, indicating a possible induced anti-tumor immune response.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Evaluation demonstrates anti-tumor efficacy of 212Pb-PSMA therapy in immunocompetent prostate cancer models, suggesting promising therapeutic implications.

Cite This Study

Monterosso et al. (2026) studied this question.

synapsesocial.com/papers/69d1fd8ea79560c99a0a3a36 https://doi.org/10.1158/1538-7445.am2026-2855

View Full Paper

Ask AI

Bookmark

Implication

Evaluation demonstrates anti-tumor efficacy of 212Pb-PSMA therapy in immunocompetent prostate cancer models, suggesting promising therapeutic implications.

Evaluation of 212Pb-PSMA Radioligand Therapy in Prostate Cancer Models

Key Points

Discussion

Implication

Cite This Study

Evaluation of 212Pb-PSMA Radioligand Therapy in Prostate Cancer Models

Key Points

Discussion

Implication

Cite This Study

Keep reading

Keep reading